Resmed OverviewResmed EBIT
EBIT (Earnings Before Interest and Taxes) analysis for RMD.
Quarterly EBIT
$499.81M
↑ 16.88% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
$1.91B
↑ 18.19% YoY
Trailing 12 months ending Mar 31, 2026
Resmed OverviewEBIT (Earnings Before Interest and Taxes) analysis for RMD.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026